{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:56:34Z","timestamp":1783749394743,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2015SF\u2013998-MaReCa"],"award-info":[{"award-number":["TMA2015SF\u2013998-MaReCa"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>African countries stand out globally as the region seemingly least affected by the COVID-19 pandemic, caused by the virus SARS-CoV-2. Besides a younger population and potential pre-existing immunity to a SARS-CoV-2-like virus, it has been hypothesized that co-infection or recent history of <jats:italic>Plasmodium falciparum<\/jats:italic> malaria may be protective of COVID-19 severity and mortality. The number of COVID-19 cases and deaths, however, may be vastly undercounted. Very little is known about the extent to which the Tanzanian population has been exposed to SARS-CoV-2. Here, we investigated the seroprevalence of IgG to SARS-CoV-2 spike protein in two Tanzanian rural communities 1\u00bd\u00a0years into the pandemic and the association of coinciding malaria infection and exposure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>During a malariometric survey in July 2021 in two villages in north-eastern Tanzania, blood samples were taken from 501 participants (0\u201319\u00a0years old). Malaria was detected by mRDT and microscopy. Levels of IgG against the spike protein of SARS-CoV-2 were measured by ELISA as well as IgG against five different antigens of <jats:italic>P. falciparum<\/jats:italic>; CIDR\u03b11.1, CIDR\u03b11.4 and CIDR\u03b11.5 of PfEMP1 and GLURP and MSP3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The seroprevalence of SARS-CoV-2 IgG was 39.7% (106\/267) in Kwamasimba and 32.5% (76\/234) in Mkokola. In both villages the odds of being seropositive increased significantly with age (AOR\u2009=\u20091.12, 95% CI 1.07\u20131.17, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). <jats:italic>P. falciparum<\/jats:italic> malaria prevalence by blood smear microscopy was 7.9% in Kwamasimba and 2.1% in Mkokola. 81.3% and 70.5% in Kwamasimba and Mkokola, respectively, showed recognition of minimum one malaria antigen. Residing in Kwamasimba was associated with a broader recognition (AOR\u2009=\u20091.91, 95% CI 1.34\u20132.71, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The recognition of malaria antigens increased significantly with age in both villages (AOR\u2009=\u20091.12; 95% CI 1.08\u20131.16, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Being SARS-CoV-2 seropositive did not associate with the breadth of malaria antigen recognition when adjusting for age (AOR\u2009=\u20090.99; 95% CI 0.83\u20131.18; <jats:italic>p<\/jats:italic>\u2009=\u20090.91).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>More than a third of the children and adolescents in two rural communities in Tanzania had antibodies to SARS-CoV-2. In particular, the adolescents were seropositive but being seropositive did not associate with the status of coinciding malaria infections or previous exposure. In Tanzania, natural immunity may have developed fast, potentially protecting a substantial part of the population from later variants.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07820-6","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T09:03:04Z","timestamp":1668243784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021"],"prefix":"10.1186","volume":"22","author":[{"given":"Eric","family":"Lyimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Fougeroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anangisye","family":"Malabeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Mbwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Hayuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Liheluka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samwel","family":"Gesase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lavstsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P. A.","family":"Lusingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T. R.","family":"Minja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"issue":"13","key":"7820_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199\u2013207.","journal-title":"N Engl J Med"},{"issue":"11","key":"7820_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"key":"7820_CR3","doi-asserted-by":"publisher","first-page":"587269","DOI":"10.3389\/fcimb.2020.587269","volume":"10","author":"MY Wang","year":"2020","unstructured":"Wang MY, Zhao R, Gao LJ, et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10223","key":"7820_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514\u201323.","journal-title":"Lancet"},{"key":"7820_CR5","unstructured":"Coronavirus disease (COVID-19). https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_3. Accessed 20 Apr 2022."},{"issue":"1","key":"7820_CR6","doi-asserted-by":"publisher","first-page":"e2035057","DOI":"10.1001\/jamanetworkopen.2020.35057","volume":"4","author":"MA Johansson","year":"2021","unstructured":"Johansson MA, Quandelacy TM, Kada S, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4(1):e2035057.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"7820_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1473-3099(20)30700-3","volume":"21","author":"DJ Weiss","year":"2021","unstructured":"Weiss DJ, Bertozzi-Villa A, Rumisha SF, et al. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis. 2021;21(1):59\u201369.","journal-title":"Lancet Infect Dis"},{"key":"7820_CR8","doi-asserted-by":"publisher","DOI":"10.30875\/6c551ba0-en","volume-title":"World malaria report 2021","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. World malaria report 2021. Geneva: World Health Organization; 2021."},{"key":"7820_CR9","doi-asserted-by":"publisher","DOI":"10.30875\/60123dd4-en","volume-title":"World malaria report 2020: 20 years of global progress and challenges","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization; 2020."},{"issue":"10238","key":"7820_CR10","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(20)31089-8","volume":"395","author":"R Cash","year":"2020","unstructured":"Cash R, Patel V. Has COVID-19 subverted global health? Lancet. 2020;395(10238):1687\u20138.","journal-title":"Lancet"},{"issue":"10284","key":"7820_CR11","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/S0140-6736(21)00678-4","volume":"397","author":"SG Mfinanga","year":"2021","unstructured":"Mfinanga SG, Mnyambwa NP, Minja DT, et al. Tanzania\u2019s position on the COVID-19 pandemic. Lancet. 2021;397(10284):1542\u20133.","journal-title":"Lancet"},{"issue":"11","key":"7820_CR12","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.3390\/v13112325","volume":"13","author":"R Borrega","year":"2021","unstructured":"Borrega R, Nelson DKS, Koval AP, et al. Cross-reactive antibodies to SARS-CoV-2 and MERS-CoV in pre-COVID-19 blood samples from Sierra Leoneans. Viruses. 2021;13(11):2325.","journal-title":"Viruses"},{"key":"7820_CR13","doi-asserted-by":"crossref","unstructured":"Souris M, Tshilolo L, Parzy D, et al. Pre-pandemic SARS-CoV-2 potential natural immunity among population of the Democratic Republic of Congo. medRxiv 2021:2021.2004.2028.21256243.","DOI":"10.1101\/2021.04.28.21256243"},{"key":"7820_CR14","doi-asserted-by":"publisher","first-page":"565625","DOI":"10.3389\/fimmu.2021.565625","volume":"12","author":"A Kalungi","year":"2021","unstructured":"Kalungi A, Kinyanda E, Akena DH, et al. Less severe cases of COVID-19 in Sub-Saharan Africa: could co-infection or a recent history of Plasmodium falciparum infection be protective? Front Immunol. 2021;12:565625.","journal-title":"Front Immunol"},{"issue":"1","key":"7820_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12879-022-07064-4","volume":"22","author":"SA Osei","year":"2022","unstructured":"Osei SA, Biney RP, Anning AS, et al. Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link? BMC Infect Dis. 2022;22(1):78.","journal-title":"BMC Infect Dis"},{"key":"7820_CR16","unstructured":"Six in seven COVID-19 infections go undetected in Africa. https:\/\/www.afro.who.int\/news\/six-seven-covid-19-infections-go-undetected-africa. Accessed 20 Apr."},{"key":"7820_CR17","doi-asserted-by":"publisher","first-page":"e008793","DOI":"10.1136\/bmjgh-2022-008793","volume":"7","author":"HC Lewis","year":"2022","unstructured":"Lewis HC, Ware H, Whelan MG, et al. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Glob Health. 2022;7:e008793.","journal-title":"BMJ Glob Health"},{"key":"7820_CR18","unstructured":"Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/region\/afro\/country\/tz. Accessed 06th May 2022."},{"issue":"6485","key":"7820_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444\u20138.","journal-title":"Science"},{"issue":"7807","key":"7820_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215\u201320.","journal-title":"Nature"},{"issue":"7815","key":"7820_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto D, Park YJ, Beltramello M, et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020;583(7815):290\u20135.","journal-title":"Nature"},{"key":"7820_CR22","doi-asserted-by":"crossref","unstructured":"Seydoux E, Homad LJ, MacCamy AJ, et al. Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual. bioRxiv 2020.","DOI":"10.1101\/2020.05.12.091298"},{"issue":"4","key":"7820_CR23","doi-asserted-by":"publisher","first-page":"e00841-16","DOI":"10.1128\/IAI.00841-16","volume":"85","author":"SI Mkumbaye","year":"2017","unstructured":"Mkumbaye SI, Wang CW, Lyimo E, et al. The severity of Plasmodium falciparum infection is associated with transcript levels of var genes encoding endothelial protein C receptor-binding P. falciparum erythrocyte membrane protein 1. Infect Immun. 2017;85(4):e00841-16.","journal-title":"Infect Immun"},{"issue":"7455","key":"7820_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature12216","volume":"498","author":"L Turner","year":"2013","unstructured":"Turner L, Lavstsen T, Berger SS, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature. 2013;498(7455):502\u20135.","journal-title":"Nature"},{"issue":"1","key":"7820_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12936-019-2831-x","volume":"18","author":"R Adamou","year":"2019","unstructured":"Adamou R, Dechavanne C, Sadissou I, et al. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort. Malar J. 2019;18(1):194.","journal-title":"Malar J"},{"key":"7820_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/1475-2875-9-216","volume":"9","author":"BP Mmbando","year":"2010","unstructured":"Mmbando BP, Vestergaard LS, Kitua AY, et al. A progressive declining in the burden of malaria in north-eastern Tanzania. Malar J. 2010;9:216.","journal-title":"Malar J"},{"issue":"1","key":"7820_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12936-021-03952-3","volume":"20","author":"PM Hayuma","year":"2021","unstructured":"Hayuma PM, Wang CW, Liheluka E, et al. Prevalence of asymptomatic malaria, submicroscopic parasitaemia and anaemia in Korogwe District, north-eastern Tanzania. Malar J. 2021;20(1):424.","journal-title":"Malar J"},{"issue":"1","key":"7820_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41467-020-20251-8","volume":"12","author":"C Fougeroux","year":"2021","unstructured":"Fougeroux C, Goksoyr L, Idorn M, et al. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity. Nat Commun. 2021;12(1):324.","journal-title":"Nat Commun"},{"issue":"8","key":"7820_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1590\/0074-02760160119","volume":"111","author":"F Lardeux","year":"2016","unstructured":"Lardeux F, Torrico G, Aliaga C. Calculation of the ELISA\u2019s cut-off based on the change-point analysis method for detection of Trypanosoma cruzi infection in Bolivian dogs in the absence of controls. Mem Inst Oswaldo Cruz. 2016;111(8):501\u20134.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"7820_CR30","unstructured":"First WHO International Standard Anti-SARS-CoV-2 Immunoglobulin (Human) NIBSC code: 20\/136. National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG. WHO International Laboratory for Biological Standards, UK Official Medicines Control Laboratory. https:\/\/www.nibsc.org\/products.aspx. Accessed 05 May 2022."},{"issue":"8","key":"7820_CR31","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1128\/IAI.00271-15","volume":"83","author":"L Turner","year":"2015","unstructured":"Turner L, Lavstsen T, Mmbando BP, et al. IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria. Infect Immun. 2015;83(8):3096\u2013103.","journal-title":"Infect Immun"},{"issue":"12","key":"7820_CR32","doi-asserted-by":"publisher","first-page":"e29025","DOI":"10.1371\/journal.pone.0029025","volume":"6","author":"L Turner","year":"2011","unstructured":"Turner L, Wang CW, Lavstsen T, et al. Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naive volunteers. PLoS ONE. 2011;6(12):e29025.","journal-title":"PLoS ONE"},{"key":"7820_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1475-2875-7-108","volume":"7","author":"GK Cham","year":"2008","unstructured":"Cham GK, Kurtis J, Lusingu J, et al. A semi-automated multiplex high-throughput assay for measuring IgG antibodies against Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) domains in small volumes of plasma. Malar J. 2008;7:108.","journal-title":"Malar J"},{"key":"7820_CR34","doi-asserted-by":"crossref","unstructured":"Bergeri I, Whelan M, Ware H, et al. Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020\u2013May 2022. 2022:2021.2012.2014.21267791.","DOI":"10.1101\/2021.12.14.21267791"},{"issue":"7844","key":"7820_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","volume":"590","author":"M O'Driscoll","year":"2021","unstructured":"O\u2019Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140\u20135.","journal-title":"Nature"},{"issue":"3","key":"7820_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cmi.2020.10.020","volume":"27","author":"A Rostami","year":"2021","unstructured":"Rostami A, Sepidarkish M, Leeflang MMG, et al. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(3):331\u201340.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"7820_CR37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/archdischild-2020-320558","volume":"106","author":"T Waterfield","year":"2021","unstructured":"Waterfield T, Watson C, Moore R, et al. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study. Arch Dis Child. 2021;106(7):680\u20136.","journal-title":"Arch Dis Child"},{"issue":"1","key":"7820_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.dr.2007.08.002","volume":"28","author":"L Steinberg","year":"2008","unstructured":"Steinberg L. A social neuroscience perspective on adolescent risk-taking. Dev Rev. 2008;28(1):78\u2013106.","journal-title":"Dev Rev"},{"issue":"3","key":"7820_CR39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/QCO.0b013e3283607a58","volume":"26","author":"B Lindsey","year":"2013","unstructured":"Lindsey B, Kampmann B, Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis. 2013;26(3):248\u201353.","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"7820_CR40","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1038\/s41598-021-87535-x","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Yang P, Zheng J, et al. Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants. Sci Rep. 2021;11(1):8021.","journal-title":"Sci Rep"},{"issue":"6","key":"7820_CR41","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/antibiotics11060808","volume":"11","author":"OS Ayosanmi","year":"2022","unstructured":"Ayosanmi OS, Alli BY, Akingbule OA, et al. Prevalence and correlates of self-medication practices for prevention and treatment of COVID-19: a systematic review. Antibiotics (Basel). 2022;11(6):808.","journal-title":"Antibiotics (Basel)"},{"key":"7820_CR42","first-page":"23337","volume":"9","author":"MM Mercado-Reyes","year":"2022","unstructured":"Mercado-Reyes MM, Daza M, Pacheco A, et al. Seroprevalence of SARS-CoV-2 antibodies in children and adolescents: results from a population-based survey in 10 Colombian cities. Glob Pediatr Health. 2022;9:23337.","journal-title":"Glob Pediatr Health"},{"key":"7820_CR43","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World Urbanization Prospects: The 2018 Revision, Online Edition. 2018. https:\/\/population.un.org\/wup\/Download\/."},{"issue":"9","key":"7820_CR44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y, Yang C, Xu XF, et al. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41(9):1141\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"7820_CR45","doi-asserted-by":"publisher","first-page":"657006","DOI":"10.3389\/fmed.2021.657006","volume":"8","author":"WM Song","year":"2021","unstructured":"Song WM, Zhao JY, Zhang QY, et al. COVID-19 and tuberculosis coinfection: an overview of case reports\/case series and meta-analysis. Front Med (Lausanne). 2021;8:657006.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"7820_CR46","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","volume":"11","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo P, Heilbrunn ES, Ssentongo AE, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6283.","journal-title":"Sci Rep"},{"key":"7820_CR47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijid.2021.11.040","volume":"114","author":"E Petersen","year":"2022","unstructured":"Petersen E, Ntoumi F, Hui DS, et al. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529)\u2014highlights Africa\u2019s research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2022;114:268\u201372.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"7820_CR48","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/v14030533","volume":"14","author":"D Kim","year":"2022","unstructured":"Kim D, Ali ST, Kim S, et al. Estimation of serial interval and reproduction number to quantify the transmissibility of SARS-CoV-2 omicron variant in South Korea. Viruses. 2022;14(3):533.","journal-title":"Viruses"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07820-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07820-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07820-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T09:04:16Z","timestamp":1668243856000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07820-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7820"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07820-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from Tanzania's Medical Research Coordinating Committee (MRCC). Informed consent and\/or assent was obtained from all subjects and\/or their legal guardian(s). During the survey the Swahili language was used to convey oral and written information about the study objectives, procedures, confidentiality, and voluntary participation. Prior to the signing of the informed consent or assent forms, participants were given an opportunity to query any of the study\u2019s objectives or procedures. Witnesses assisted with the informed consent or assent for study participants who were unable to read or write. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"846"}}